Latest Press Releases

Unique Navigated Knee Replacement: A First in East

A 63-year old English school teacher from Gariahat, Mrs. Riddhima Chatterjee (name changed), was in an acute knee pain for more than 8 years. Symptoms of knee arthritis were clear and the condition worsened gradually over years. The intensity of pain increased so much that she couldn’t continue ever...

SRL Diagnostics bags ‘Best Diagnostics Centre’ Award at CNBC-TV18’s India Healthcare & Wellness Awards 2017-18

SRL Diagnostics, India’s largest and preferred diagnostics chain, has bagged the prestigious "Best Diagnostics Centre” award at the CNBC-TV18’s prestigious India Healthcare & Wellness Awards 2017-18 held in Mumbai. Mr Arindam Haldar, CEO, SRL Diagnostics accepted the award on behalf of the company. ...

One Drop Announces Blood Glucose Prediction and Automated Decision Support

One Drop to launch Blood Glucose Prediction and Automated Decision Support, expanding upon the company's industry-leading digital diabetes self-management platform ...

Diabeloop Insulin Delivery System May Significantly Improve Glycemic Control for People with Type 1 Diabetes

Multi-center study compares closed-loop device to standard open-loop system in a home setting ...

Fully Implantable, Continuous Glucose Monitoring Sensor Provided Accuracy for Six Months in Adolescents and Adults with Type 1 Diabetes

...

Dual-Hormone, Artificial Pancreas with Insulin and Pramlintide Significantly Improves Glucose Levels, Compared to Insulin-Only Artificial Pancreas

...

Omnipod® Hybrid Closed-Loop Insulin Delivery System Significantly Improves Glycemic Control in Adults with Type 1 Diabetes

...

Tresiba® demonstrated significantly lower A1C and rates of hypoglycaemia versus insulin glargine U-300 in real-world evidence study

Adults with type 2 diabetes treated with Tresiba® (insulin degludec injection) had a significant reduction in A1C and a 30% lower rate of hypoglycaemic episodes after starting basal insulin ORLANDO, Fla. , June 23, 2018 /PRNewswire/ -- Findings from CONFIRM – a large, retrospective real-worl...

Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

ORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection) had a significant reduction in HbA 1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONF...

Ozempic® Provided Greater Weight Reductions for Adults With a Baseline BMI =25kg/m2 Than Those With Lower Baseline BMI <25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

ORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Poster Presentation #1083-P Ozempic ® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the grea...

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

ORLANDO, Florida , June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The trial ev...

One Third of Participants in a Workforce Study Reduce Risk for Diabetes after Employer Wellness Screening and Behavioral Counseling, Finds Quest Diagnostics Study

Late-breaker presentation at the 78th American Diabetes Association Scientific Sessions shows glucose levels and hemoglobin A1c in one third of at risk participants fell to normal levels; more than one-quarter of participants lost five percent or more of body weight ...

Dr. John R. Burroughs of Springs Aesthetics Now Offering vFit PLUS Feminine Wellness Treatment Device

vFit PLUS a proven and safe at-home feminine wellness device that improves vaginal health COLORADO SPRINGS, Colo. , June 23, 2018 /PRNewswire-PRWeb/ -- Dr. John R. Burroughs , the Medical Director of Springs Aesthetics, is proud to be the first medical spa in Colorado Springs to offer vFi...

Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

INVOKANA® nearly doubled the likelihood of clinically significant weight loss compared to GLP-1s TITUSVILLE, N.J. and ORLANDO, Fla. , June 23, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies compari...

Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH

Fractyl also announces one-year safety and efficacy data from the multicenter Revita-1 clinical trial of the Revita DMR system targeting the duodenal lining in patients with type 2 diabetes. LEXINGTON, Mass. and ORLANDO, Fla. , June 23, 2018 /PRNewswire/ -- Fractyl Laboratories Inc. ( Fr...

New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes

...

Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors

- In separate analysis, Jardiance (empagliflozin) reduced risk of CV death or hospitalization for heart failure in adults with CV disease and type 2 diabetes, irrespective of their CV risk at study start ...

Tresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycemia versus insulin Toujeo® in real-world evidence study

Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection) had a significant reduction in HbA 1c and a 30 per cent lower rate of hypoglycemic episodes compared with those treated with Toujeo ® (insulin glargine U300) after starting basal insulin TORONTO , June 23,...

Gaumard's Growing Family Takes Center Stage at AWHONN '18

MIAMI , June 23, 2018 /PRNewswire/ -- With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual convention, from today through June 27 in Tampa , to see Gaumard's growing family of maternal and neonatal pati...

Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications

Adults treated with Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 weeks ORLANDO, Fla. , June 23, 2018 /PRNewswire/ -- Xultophy ® 100/3.6 (insulin ...

Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

BAGSVÆRD, Denmark , June 23, 2018 /PRNewswire/ -- Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy ® (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 wee...

New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes

Data Presented at the 78th Scientific Sessions of the American Diabetes Association ...

Two-year Data from ViaCyte's STEP ONE Clinical Trial Presented at ADA 2018

Two-year data show survival of mature endocrine islet cells when PEC-Encap is well vascularized; encouraging non-clinical data on modified Encaptra Cell Delivery System may support resuming trial enrollment in 2019. ...

Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes

Data from a Phase 2 trial will be presented for the first time at the ADA's 78th Scientific Sessions® ...

Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO 20th World Congress on Gastrointestinal Cancer

- Median Overall Survival (mOS) was not reached; OS data are fully mature through 12.6 months - ...

Xcode Life Announces the South Asian Genome (SAGE) Project

Promotional offer: Free Xcode Ancestry report for all eligible individuals ...

Women's Excellence Treats the Whole Woman During Menopause

Women's Excellence in Menopause is a specialty area of the practice for women that have symptoms of menopause LAKE ORION, Mich. , June 23, 2018 /PRNewswire-PRWeb/ -- Women's Excellence's goal is treating the whole person. All of their services reflect the comprehensive nature of their philos...

Women's Excellence Now Offers Solutions To Infertility Associated with Endometriosis

Endometriosis is a very complicated disease process that needs a well thought out treatment plan. BIRMINGHAM , LAKE ORION , CLARKSTON , ROCHESTER and WEST BLOOMFIELD, Mich. , June 23, 2018 /PRNewswire-PRWeb/ -- Many women are confused about their direction with respect to fertility once...

Health Data Decisions to Deliver HEDIS® Track Keynote on Social Determinants of Health at RISE Qualipalooza Leadership Summit 2018

Health Data Decisions' CEO Michael Blumental will partner with Janine Sala, Associate Director of Clinical Quality at UnitedHealthcare, to deliver the keynote for the HEDIS® track at the 3rd Annual RISE Qualipalooza Leadership Summit on Monday, June 25th at the Arizona Biltmore in Phoenix. PHO...

Cellenkos, Inc. Announces Neuroinflammation Research Collaboration with The University of Texas Health Science Center at Houston

...

ALK and ROS1 Clones from CST Featured in Latest Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer

Two Cell Signaling Technology antibody clones, ALK (D5F3®) and ROS1 (D4D6®), were featured in an article authored by the Tumor Biomarker Experts of the Chinese Society of Clinical Oncology. The article, Guidelines for diagnosis and treatment of ALK and ROS1 positive non-small cell lung cancer in Ch...

Revenue Maximization Group Reiterates Its Full Service Offering for Former CareSync Clients

The stunning announcement that CareSync, a Chronic Care Management company has shuttered its doors. ...

Digital Technology Consortium Report Provides Window into Future Trends for Digital Marketing Budget, Staffing and Performance Measurement

CHAPEL HILL, N.C. , June 22, 2018 /PRNewswire/ -- Pharmaceutical companies are increasingly using digital engagement channels to more effectively communicate with their customers. Unlike many other operational areas of pharma, the performance of digital marketing can be measured to evaluate th...

International Multi-Centre Collaboration Reveals that Cannabigerol Acts Directly on Cannabinoid Receptors CB1 and CB2

In-vitro affinity and efficacy trials indicate that cannabigerol (CBG) acts as a competitive partial agonist of the orthosteric binding site of cannabinoid receptor subtype 2 (CB2R). ...

Muhammad Yasser Darkazally, M.D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Internal Medicine in recognition of his role as an Internist at Saint Francis Hospitalists

...

Canopy Health's South Bay Expansion Approved by California Department of Managed Health Care

Official approval expands Canopy Health's service area to include additional medical groups and hospitals. ...

Trovagene Announces Leadership Change

William Welch has resigned as CEO and Director ...

ADDISON CARE: Virtual Caregiver System Poised to Dramatically Reduce Cost of Home Health Care

It sounds like a something out of a futuristic movie, and yet it's real and it's here today. A virtual caregiver, the next level of virtual assistants. She's more than a tabletop speaker grill. ...

Global Parenteral Nutrition Markets, 2016-2018 & 2024 - Rising Number of Premature Births Enhances Need for Parenteral Nutrition

...

China IVD Market 2018-2024: Roche Captures Maximum Share of the China IVD Market

...

Eidos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

SAN FRANCISCO , June 22, 2018 /PRNewswire/ -- Eidos Therapeutics, Inc. (Nasdaq: EIDX), a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR), today announced the closing of its initial publi...

U.S. District Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit

...

Identifying and Reducing Gender Gaps in Diabetes--Care, Research and the Health Care Profession

...

Global Blood Glucose Monitoring Devices Market to 2024 - Market to Grow with a CAGR of 8.80%

...

TVA Medical Receives FDA De Novo Marketing Authorization For everlinQ® endoAVF System

- Novel technology using magnetic catheters and radiofrequency energy creates an arteriovenous fistula for hemodialysis without open surgery ...

Information Update - Health Canada reminds Canadians of the limitations of fentanyl test strips being used to check street drugs before consumption

OTTAWA , June 22, 2018 /CNW/ - With the growing availability of fentanyl test strips on store shelves and online, Health Canada would like to remind Canadians of the potential limitations when using fentanyl test strips to detect fentanyl or other deadly substances in street drugs before consum...

AANP Commends US House of Representatives on Passage of H.R. 6

Legislation Would Make Permanent the Authorization for NPs to Prescribe Medication Assisted Therapies AUSTIN, Texas , June 22, 2018 /PRNewswire-USNewswire/ -- The American Association of Nurse Practitioners would like to thank congressional leaders for their support and leadership on H.R. 6,...

Government of Canada is consulting on proposed regulations for plain and standardized appearance for tobacco products

Proposal would help to protect Canadians, particularly youth, from the health hazards of tobacco products OTTAWA , June 22, 2018 /CNW/ - Despite decades of effort to reduce smoking rates and a steady decline in the percentage of Canadians who smoke, tobacco use remains the leading prevent...